SELZENTRY 300 MG TABLET

$28.0198per EA

High Outlier

Strength

300 mg/1

Manufacturer

NDC

49702022418

Classification

Brand

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

3/19/2025

Active Ingredients

Approval Type

New Drug (NDA)

FDA Application

On Market Since

5/16/2011

Pharmacological Classes

Chemokine Co-receptor 5 Antagonists

0.0%

-0.0%

+10.9%

All

+60.5%

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Same classification

No related drugs found.